Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001070081-18-000045
Filing Date
2018-04-30
Accepted
2018-04-30 17:23:49
Documents
5
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice2018.htm DEFA14A 26141
2 ptctherapeuticsincnap073001.jpg GRAPHIC 80196
3 ptctherapeuticsincnap073002.jpg GRAPHIC 116560
4 ptctherapeuticsincnap073003.jpg GRAPHIC 27378
5 ptctherapeuticsincnap073004.jpg GRAPHIC 6154
  Complete submission text file 0001070081-18-000045.txt   325083
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35969 | Film No.: 18791484
SIC: 2834 Pharmaceutical Preparations